glp 1 surgery Bariatric vs GLP-1 Medications for Long-Term Weight Loss Medication vs. Bariatric Surgery for
Description
SGLT2 inhibitor (n = 12,6722
Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials
Rather than waiting for trends to be defined solely by clinical research or large-scale institutional studies, audiences are actively shaping the conversation through digital communities, personal experimentation, and selective adoption of new products
Nat Sci Sleep
[DOI] [PubMed] [Google Scholar] 302.Diakogiannaki E., Pais R., Tolhurst G., Parker H.E., Horscroft J., Rauscher B
Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al
